Systemic Atropine for Horses: Emergency Uses & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Systemic atropine is an anticholinergic medication that blocks muscarinic receptors throughout the body. In horses, that means it can reduce secretions, increase heart rate, relax some smooth muscle, and widen the pupils. Because it affects multiple organ systems at once, it is usually given by injection under close veterinary supervision, not as a routine at-home medication.

In equine medicine, systemic atropine is mainly an emergency or hospital-use drug. Your vet may reach for it when a horse has severe cholinergic signs, certain anesthesia-related heart rate problems, or a carefully selected respiratory situation where brief bronchodilation is needed. Horses are especially sensitive to atropine's effects on the gut, so even useful doses can create meaningful risk.

That balance matters. Atropine can be lifesaving in the right case, but it is not a casual medication for horses. If your horse has been prescribed systemic atropine, your vet is weighing the expected benefit against the possibility of ileus, reduced gut sounds, and colic.

The most important emergency use of systemic atropine in horses is organophosphate toxicosis. In that setting, atropine helps block the dangerous muscarinic effects of poisoning, such as heavy salivation, bronchial secretions, bronchoconstriction, and some heart-rate abnormalities. It does not fix the nicotinic effects like muscle weakness or paralysis, so horses often need additional treatment and monitoring.

Your vet may also use atropine as a preanesthetic or peri-anesthetic medication when vagal stimulation is causing problematic bradycardia, or when cholinergic signs develop during certain drug protocols. In some horses with severe lower-airway constriction, a low IV dose may be used for short-term bronchodilation or as a response test in equine asthma cases.

What atropine is not for is long-term routine management. In horses, safer alternatives are often preferred when possible because atropine can slow intestinal motility. That is why your vet may choose another anticholinergic for some situations, especially if the goal is temporary relief with less risk to the gastrointestinal tract.

Systemic atropine dosing in horses is indication-specific and route-specific, so pet parents should never try to calculate or repeat a dose without direct veterinary instructions. Published veterinary references describe a low IV dose around 0.014 mg/kg for bronchodilation in horses, with a test dose around 0.022 mg/kg IV sometimes used in selected respiratory cases. For organophosphate toxicosis, Merck lists 0.1-0.2 mg/kg IV, repeated every 10 minutes as needed to effect.

Those numbers do not mean every horse should receive atropine. Your vet will adjust for the horse's weight, hydration status, gut motility, cardiovascular status, and the reason the drug is being used. In foals, dosing decisions are even more nuanced. Merck specifically notes that atropine is not recommended in bradycardic neonatal foals when the bradycardia is secondary to hypoxia, because it can increase myocardial oxygen demand before the underlying oxygen problem is corrected.

Monitoring is a big part of dosing. Your vet may track heart rate, gut sounds, manure output, pupil size, respiratory effort, and overall comfort before deciding whether another dose is appropriate. If your horse is sent home after receiving atropine in the hospital or field, ask exactly what signs would mean you should call back right away.

The biggest concern with systemic atropine in horses is reduced intestinal motility. Even low doses may cause ileus, decreased borborygmi, abdominal discomfort, and colic. That risk is one reason many equine vets use atropine cautiously and only when the expected benefit is clear.

Other possible side effects include tachycardia, dry mucous membranes, decreased sweating or altered secretions, dilated pupils, blurred vision, urine retention, and neurologic changes such as excitement or derangement. Some horses may look more alert after appropriate atropinization, but overtreatment can push them into unwanted anticholinergic effects.

See your vet immediately if your horse develops pawing, rolling, flank watching, reduced manure output, marked abdominal distension, worsening agitation, weakness, or persistent fast heart rate after receiving atropine. In horses, side effects can move from mild to urgent quickly, especially when gut motility is affected.

Systemic atropine can interact with other medications that affect the autonomic nervous system, heart rhythm, sedation, or gastrointestinal motility. Your vet will be especially careful if your horse is already receiving other anticholinergic drugs, medications that can raise heart rate, or drugs that may slow the gut.

In emergency toxicology cases, atropine is often used alongside pralidoxime (2-PAM) for organophosphate poisoning because the two drugs address different parts of the toxicosis. In anesthesia or reversal settings, atropine may also be given when cholinergic signs develop with agents such as edrophonium or pyridostigmine. That combination can be appropriate, but it should be done by your vet because timing and monitoring matter.

Tell your vet about every medication and supplement your horse has received recently, including sedatives, bronchodilators, antiarrhythmics, colic medications, and topical or ophthalmic atropine. Even when a drug is not a strict contraindication, the combination may change the risk of tachycardia, blurred vision, urine retention, or gastrointestinal slowdown.